1Life Healthcare Inc. (ONEM): Price and Financial Metrics
GET POWR RATINGS... FREE!
ONEM POWR Grades
- ONEM scores best on the Growth dimension, with a Growth rank ahead of 56.98% of US stocks.
- The strongest trend for ONEM is in Growth, which has been heading up over the past 173 days.
- ONEM's current lowest rank is in the Sentiment metric (where it is better than 4.05% of US stocks).
ONEM Stock Summary
- 1Life Healthcare Inc's stock had its IPO on January 31, 2020, making it an older stock than merely 1.47% of US equities in our set.
- Price to trailing twelve month operating cash flow for ONEM is currently 157.17, higher than 97.35% of US stocks with positive operating cash flow.
- With a year-over-year growth in debt of 208.49%, 1Life Healthcare Inc's debt growth rate surpasses 95.19% of about US stocks.
- Stocks that are quantitatively similar to ONEM, based on their financial statements, market capitalization, and price volatility, are HCAT, NEWR, CLDR, PD, and MODN.
- ONEM's SEC filings can be seen here. And to visit 1Life Healthcare Inc's official web site, go to www.onemedical.com.
ONEM Valuation Summary
- In comparison to the median Technology stock, ONEM's price/sales ratio is 101.89% higher, now standing at 10.7.
- Over the past 17 months, ONEM's price/sales ratio has gone up $0.9.
- Over the past 17 months, ONEM's price/sales ratio has gone up $0.9.
Below are key valuation metrics over time for ONEM.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| ONEM | 2021-05-10 | 13.9 | 9.6 | -59.4 | -73.9 |
| ONEM | 2021-05-04 | 15.1 | 10.5 | -64.7 | -80.1 |
| ONEM | 2020-08-17 | 13.3 | 7.1 | -69.8 | -72.4 |
| ONEM | 2020-05-05 | 11.4 | -16.9 | -60.1 | -62.8 |
| ONEM | 2020-02-20 | 10.9 | -17.3 | -57.0 | -59.4 |
| ONEM | 2020-02-06 | 11.1 | -17.6 | -58.2 | -60.6 |
ONEM Price Target
For more insight on analysts targets of ONEM, see our ONEM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $49.85 | Average Broker Recommendation | 1.31 (Strong Buy) |
ONEM Stock Price Chart Interactive Chart >
ONEM Price/Volume Stats
| Current price | $34.66 | 52-week high | $59.82 |
| Prev. close | $34.77 | 52-week low | $25.40 |
| Day low | $34.62 | Volume | 368,541 |
| Day high | $35.08 | Avg. volume | 1,328,317 |
| 50-day MA | $37.72 | Dividend yield | N/A |
| 200-day MA | $38.64 | Market Cap | 4.76B |
1Life Healthcare Inc. (ONEM) Company Bio
1Life Healthcare, Inc. engages in the provision of healthcare membership services. It offers walk-in immunizations and lab services, behavioral health, women's health, men's health, LGBTQ+ care, pediatrics, sports medicine, lifestyle, and wellbeing programs.
Latest ONEM News From Around the Web
Below are the latest news stories about 1Life Healthcare Inc that investors may wish to consider to help them evaluate ONEM as an investment opportunity.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - KIN, SYKE, USCR, ONEM, QTS, MCFHalper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: |
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of DEH, FST, ONEM, and LATN MergersWILMINGTON, Del., June 17, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating: D8 Holdings Corp. (NYSE: DEH) regarding possible breaches of fiduciary duties and other violations of law related to D8 Holdings agreement to merge with Vicarious Surgical, Inc. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-d8-holdings-corp. FAST Acquisition Corp. (NYSE: FST) regarding possible breaches of fiduciary duties and other violation |
INVESTIGATION ALERT: Halper Sadeh LLP Investigates ONEM, ALTA, XOG, AMRB; Shareholders are Encouraged to Contact the FirmNEW YORK, June 15, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 1Life Healthcare, Inc. (NASDAQ: ONEM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Iora Health. Under the terms of the merger, 1Life Healthcare will acquire Iora Health in an all-stock transaction. Upon closing, 1Life Healthcare shareholders are expected to own appr |
1LIFE HEALTHCARE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates 1Life Healthcare, Inc. - ONEMNEW ORLEANS, Jun 15, 2021--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Iora Health to 1Life Healthcare, Inc. (NasdaqGS: ONEM) ("the Company"). Under the terms of the proposed transaction, 1Life is acquiring Iora Health in an all-stock transaction valued at approximately $2.1 billion. KSF is seeking to determine whether the merger and the process that led to it are adequate and fair to th |
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ONEM, QTS, EBSB, MDP; Shareholders are Encouraged to Contact the FirmNEW YORK, NY / ACCESSWIRE / June 15, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:1Life Healthcare, Inc. (NASDAQ:ONEM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Iora Health. |
ONEM Price Returns
| 1-mo | 4.59% |
| 3-mo | -10.55% |
| 6-mo | -20.30% |
| 1-year | 0.55% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -20.60% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Loading social stream, please wait...